Clinical Investigation On Drug Interaction of CVD: Evaluation on LCMS - Couverture souple

Das, Rakesh; Pal, Tapan Kumar

 
9786134963794: Clinical Investigation On Drug Interaction of CVD: Evaluation on LCMS
Couverture souple
ISBN 10 : 6134963798 ISBN 13 : 9786134963794
Editeur : LAP LAMBERT Academic Publishing, 2018

Synopsis

One of the Pharmaceutical tablet dosage form which categorized under Cardiovascular combined formulation (Atorvastatin 10mg & Olmesartan 20mg) discloses Clinical, Markets, patients and community health feedbacks and reported high morbidity rate on chronic stage therapy. Though logics behind Atorvastatin (ATVS) & Olmesartan (OLM) combination i.e, Anti-atherosclerotic & anti-hypertensive must flourish best anti-hypertensive activity, but in real fact it’s just reverse. The false propitious prescription persisting this formulation is unsafe for health and thus required post marketed re-investigation as per concerning Pharmacovigilance study. The misuse and malpractice of drugs by clinicians in patient’s population particularly targeted hypertensive volunteers, on relying to this anti-hypertensive /Cardiovascular drug formulation seems to be hazardous to individual as well as community health. So, evaluation of this fact was undertaken in PhD project with scrutinizing all physiological parameters correlating to endogenous biochemical systemic variation depending on these drugs pharmacology.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

One of the Pharmaceutical tablet dosage form which categorized under Cardiovascular combined formulation (Atorvastatin 10mg & Olmesartan 20mg) discloses Clinical, Markets, patients and community health feedbacks and reported high morbidity rate on chronic stage therapy. Though logics behind Atorvastatin (ATVS) & Olmesartan (OLM) combination i.e, Anti-atherosclerotic & anti-hypertensive must flourish best anti-hypertensive activity, but in real fact it’s just reverse. The false propitious prescription persisting this formulation is unsafe for health and thus required post marketed re-investigation as per concerning Pharmacovigilance study. The misuse and malpractice of drugs by clinicians in patient’s population particularly targeted hypertensive volunteers, on relying to this anti-hypertensive /Cardiovascular drug formulation seems to be hazardous to individual as well as community health. So, evaluation of this fact was undertaken in PhD project with scrutinizing all physiological parameters correlating to endogenous biochemical systemic variation depending on these drugs pharmacology.

Biographie de l'auteur

Dr. Rakesh Das is Associate Professor and joined the Teerthanker Mahaveer College of Pharmacy at the Teerthanker Mahaveer University, UP, India in 2017. He has 23 innovated scientific International publications with 1st author only and acquires new concept of scientific touch. He has M.Pharm; PhD. from Jadavpur University, W.B., Kolkata, India.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2018
Langue
anglais
ISBN 10 
6134963798
ISBN 13 
9786134963794
Reliure
Broché
Nombre de pages
352
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne